λΆλ―Έ μ°νΈλ± νλ μ
**λΆλ―Έ μ°νΈλ± νλ μ**λ **λλΆ μ°νΈλ±** λ° **ν μ¬μ€ μ°νΈλ±** κ΅μμ μν μ€λ μ μΉλ£νκΈ° μν νΉμ΄μ ν΄λ μ μ λλ€. μλ Έλ/μ 리쑰λ μ°νΈλ±μ λ μ μ€ννμ§ λͺ»ν©λλ€. μ°νΈλ± λ μ μ£Όλ‘ **μ κ²½λ μ±**μ μΌμΌν€λ©° μμ μ¦μμ΄ μ§μ°λμ΄ λνλ μ μμΌλ―λ‘, κ΅μμ΄ μμ¬λλ λλ¬Όμ 24~48μκ° λμ μ μνμ¬ μ§μ€ κ΄μ°°νλ κ²μ΄ κΆμ₯λ©λλ€.
μμ© κΈ°μ : Antivenins provide **passive immunity** by supplying pre-formed neutralizing antibodies (globulins) derived from horses hyperimmunized with coral snake venom. * **Mechanism:** The antibodies directly bind to the complex venom proteins (specifically **alpha-neurotoxins**) in the patient's bloodstream. * **Pathway:** Venom-antibody binding β prevents neurotoxins from attaching to **nicotinic acetylcholine receptors** at the neuromuscular junction β halts the progression of flaccid paralysis and respiratory depression. * Each vial neutralizes approximately 2 mg of *M. fulvius fulvius* venom.
λλ¬Ό μ’ λ³ μ©λ
- Coral Snake envenomation Β· 1-2 vials of antivenin. Initially give one vial, by diluting to 100-250 mL of crystalloid fluids and initially administering by slow IV . In smaller patients, adjust infusion volume to prevent fluid overload. Give additional vials as indicated by the progression of the syndrome. Β· slow IV Β· Initially, then as indicated Β· Dose necessary is calculated relative to the amount of venom injected and the body mass of patient. Smaller patients may require higher doses.
- Coral Snake envenomation (systemic effects) Β· Administer 1-2 vials slowly IV diluted in 250-500 mL saline or lactated Ringer's. Β· IV Β· Once, use only if necessary Β· Use only if necessary to treat systemic effects, otherwise avoid use. Administer antihistamines; corticosteroids are contraindicated. May be used with Crotilidae antivenin.
- Coral Snake envenomation Β· 1-2 vials initially, and more in 4-6 hours if necessary Β· IV Β· initially, and more in 4-6 hours if necessary Β· Therapy is best started within 4 hours after envenomation. Supportive care includes broad-spectrum antibiotics, fluid therapy and mechanical ventilation if necessary. Corticosteroids are not recommended.
- Coral Snake envenomation Β· 1-2 vials of antivenin. Initially give one vial, by diluting to 100-250 mL of crystalloid fluids and initially administering by slow IV . In smaller patients, adjust infusion volume to prevent fluid overload. Give additional vials as indicated by the progression of the syndrome. Β· slow IV Β· Initially, then as indicated Β· Dose necessary is calculated relative to the amount of venom injected and the body mass of patient. Smaller patients may require higher doses (as venom amount/kg body weight is higher).
μ©λμ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μ°Έκ³ μλ£μ λλ€. νμ μ΅μ λΌλ²¨κ³Ό κ°λ³ νμμ λν΄ νμΈνμμμ€.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Envenomation by Sonoran or Arizona Coral Snake (Micruroides euryxanthus)
μ΄μλ°μ
- Hypersensitivity reactions
- Anaphylaxis (incidence <2%)
- Anaphylactoid reactions
- Serum sickness
- Erythema and wheal formation (at injection site during sensitivity testing)
μ½λ¬Ό μνΈμμ©
- Analgesics / Sedatives Β· May mask the clinical signs associated with the venom; use initially with caution.
- Antihistamines Β· Theoretical potentiation of venom, though undocumented. Diphenhydramine is routinely used by clinicians for pretreatment.
- Beta-blockers Β· May mask the early signs associated with anaphylaxis.
- Corticosteroids Β· Contraindicated for the treatment of snakebite envenomation itself, but may be useful to treat secondary anaphylaxis.
λͺ¨λν°λ§
- Signs associated with an allergic response to the antivenin (anaphylaxis, anaphylactoid-reactions, serum sickness)
- Cardiorespiratory monitoring
- Mechanical ventilation parameters (if necessary)
- Pulse oximetry
κ³Όμ©λ
Specific overdosage information is not provided, but in smaller patients, care must be taken to adjust the infusion volume of the crystalloid diluent to prevent **fluid overload**.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.